Karen Appold

Healthcare experts detail three policies that MCOs should keep a close eye on.

What these healthcare industry disruptors are, and how they could impact cost and quality of care.

Payers challenged a 2014 CMS Overpayment Rule and won. Here’s what healthcare executives should know.

FDA issued a recall of popular blood pressure drugs. Here’s what you need to know.

Here are four other things that MCOs should know about a first-of-its kind targeted RNA-based therapy to treat a rare disease.

Although the act would not prohibit manufacturers from increasing prices, it could change the pricing landscape. Here’s why.

Researchers and scientists continue to develop and test new treatments for these fatal conditions. Here’s a look at some major developments in these areas.

Although Kavanaugh's paper trail on health policy is not vast, it does include some intriguing clues about how he might rule on future cases. Find out more.

The Trump Administration says AHPs will provide small businesses with more choices, access, and coverage options. Here’s what you need to know.

State policy variations related to these plans could have significant impacts on the overall insurance market. Here’s what you need to know.

When insurers stopped receiving cost-sharing reduction payments from the government last year, many significantly upped premiums for certain health plans. Here’s more on why they did it, what they did, and six things healthcare executives should know.

The law opens up new options for terminally ill patients. But how will it impact managed care organizations?

Healthcare experts weigh in on the president’s plan to lower drug prices. Here’s what they said.

Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications